{
  "slug": "zone2-cardiorespiratory-fitness",
  "round": 2,
  "date": "2026-10-14",
  "authoring_model": "Sol 6.1",
  "adversarial_reviewer": "Claude Opus 5.5 (Anthropic)",
  "canonical_path": "hsef_v53_traffic_ranks_06_10_2026-10-13\\zone2-cardiorespiratory-fitness\\zone2-cardiorespiratory-fitness.review.md",
  "level_before": "Γ",
  "level_after": "Γ",
  "confidence_before": "Moderate",
  "confidence_after": "Moderate",
  "role_before": "reinforcing / stabilizing factor",
  "role_after": "reinforcing / stabilizing factor",
  "pmids_checked": 63,
  "pmids_failed": 0,
  "retractions_or_eoc_found": 0,
  "load_bearing_claims_spotchecked": 14,
  "validator": "PASS - 0 fail, 0 warn, 30 pass",
  "findings": [
    {
      "id": "A1",
      "severity": "Major",
      "category": "scoring logic / internal consistency",
      "location": "Cap audit, precedence and B/G/D boundary - 'SC2 cap'; scorecard cap_rules_applied[SC2]",
      "original": "SC2 cap: “Biomarker change without functional/phenotypic change caps at Γ.” (cap_source: rubric, triggered: true)",
      "corrected": "SC2 cap: no universal or rubric cap binds SC2; measured VO2max is a functional phenotype, so cap 4 does not apply, and SC2's Γ ceiling comes from the boundary check (no field-valid positive perturbation at the registered scope). Scorecard row set triggered: false, cap_source: none.",
      "evidence": "The document's own SC2 Γ hard-rule audit records 'Biomarker-only improvement without organismal benefit' as NOT triggered for SC2, while the cap audit cited the same universal cap as binding; SC2's declared outcome is laboratory VO2max/VO2peak. Framework cap-precedence rule requires recording which scope each rule binds and forbids silent collision resolution.",
      "level_impact": "none"
    },
    {
      "id": "A2",
      "severity": "Minor",
      "category": "misstatement",
      "location": "Evidence and causal interpretation, paragraph on PMID 2072834",
      "original": "improved VO2max by 7% relative to nontraining controls",
      "corrected": "improved VO2max by 7%, significantly more than the change in nontraining controls",
      "evidence": "PMID 2072834 abstract: 7% is the within-group VO2max improvement in the low-intensity arm (delta 1.8 +/- 0.7 mL/kg/min), which was significantly greater (P = 0.02) than the control-group change. The review's decisive-perturbation entry [51] already stated this correctly.",
      "level_impact": "none"
    },
    {
      "id": "A3",
      "severity": "Editorial",
      "category": "rendering defects",
      "location": "throughout review.md (78 instances)",
      "original": "missing spaces around numerals; 'ErratumIn: PMIDnot supplied' (x2); 'DOI: .' (refs 9, 51); comma-run PMID lists (x3); 'UKBiobank' in prose",
      "corrected": "spaces restored; 'Erratum in: PMID not supplied'; 'DOI: not assigned in PubMed.'; '(PMID31584766, PMID40198065)' form; 'UK Biobank' in prose",
      "evidence": "Known upstream rendering defects (round-2 brief item 4). PubMed returns no DOI for PMID 22648463 and PMID 2072834, so the empty DOI fields were factually empty rather than lost.",
      "level_impact": "none"
    },
    {
      "id": "A4",
      "severity": "Minor",
      "category": "framework conformance (confidence rationale) - lead policy 2026-10-14",
      "location": "scorecard final_score.confidence_rationale",
      "original": "... density, heterogeneous controls and incomplete access set the confidence, not correctness.",
      "corrected": "Rationale rewritten to strike reviewer access as a determinant and to name only evidence density, replication and heterogeneity, with an explicit statement that access depth is recorded per ledger row and is not a determinant of the band.",
      "evidence": "Lead policy of 2026-10-14, step 1: how much of a paper the reviewer could read is neither evidence density nor reproducibility and never justifies a band. Step 2 re-derivation: What remains is a substantive evidence-quality objection, not a reading-access one: at the registered below-first-threshold scope there is one small positive controlled trial and one modern randomized null, with no independent same-scope replication, and the 63 reports use heterogeneous comparators, prescription methods and control conditions. That is nowhere near the High text's \"extensive independent replication across labs, models, and assay modalities\".",
      "band_before": "Moderate",
      "band_after": "Moderate",
      "level_impact": "none"
    }
  ],
  "rejected_findings": [
    {
      "id": "R1",
      "issue": "Headline could be Ε (or Δ) rather than Γ",
      "reasoning": "PMID 2072834 is a controlled trial whose low-intensity arm (~72% of the study-defined lactate threshold, ~53% VO2max) gained VO2max significantly more than control; paired with the null moderate-intensity-domain arm of PMID 38376995 in young adults this would read as context-specific causality. Rejected because the framework does not force it: the registered exposure is training below the FIRST measured threshold, the 1991 abstract is publisher-truncated and does not state the threshold algorithm, and the review applies cap precedence explicitly. Recorded as the leading residual uncertainty."
    },
    {
      "id": "R2",
      "issue": "Citation years one year from PubMed e-pub year (refs 10, 18, 22, 23, 34, 40, 54, 55, 59)",
      "reasoning": "Rejected per the standing print/issue vs e-pub +/-1 convention."
    },
    {
      "id": "R3",
      "issue": "Divergence 'Contested' carries no rung arithmetic",
      "reasoning": "Rejected; the framework defines Contested as the value for which no single field-implied level applies, and the scorecard records a null implied level with a stated basis."
    },
    {
      "id": "R4",
      "issue": "Momentum boilerplate",
      "reasoning": "Checked: 'Mechanistic only' with named artifacts (PMID 40198065, 42560532, 41221589). No change."
    },
    {
      "id": "R5",
      "issue": "Scope-matched aggregation misread",
      "reasoning": "Checked: primary-subclaim is the pre-registered rule and returns Γ from SC2; the declared alternatives weakest-link Β and scope-matched Γ are both correct (SC4 is both lower and narrower than the central claim's scope). No change."
    },
    {
      "id": "R6",
      "issue": "Collective authors dropped by the reference builder",
      "reasoning": "Checked all 63 reference rows; none has a blank author or leading comma."
    }
  ],
  "files_changed": [
    "zone2-cardiorespiratory-fitness.review.md",
    "zone2-cardiorespiratory-fitness.scorecard.json",
    "validator.txt",
    "ADVERSARIAL_REVIEW.md",
    "adversarial-findings.json"
  ],
  "package_level_files_not_edited": [
    "OVERVIEW.md",
    "MANIFEST.json",
    "READER.html",
    "BATCH_COMPLETION.json"
  ],
  "approval": "Approved as revised. - Claude Opus 5.5 (Anthropic), 2026-10-14.",
  "systematic_artifacts_checked": {
    "false_approval_boilerplate": "absent - fresh review, no spliced Consensus-consistency block and no 'earlier approval' clause",
    "confidence_set_from_access_depth": "CORRECTED under lead policy 2026-10-14 as finding A4: access depth struck from the rationale; band re-derived from the remaining substantive evidence-quality and reproducibility concerns and stands at Moderate.",
    "best_supported_rival_renderer_bug": "absent - models_evaluated[0] has rank_in_tournament 1 and is_nominal false; the nominal is the third entry",
    "reviewer_notes_consensus_contradiction": "absent - no spliced block; REVIEWER NOTES affirms Consensus use consistently",
    "scorecard_reviewer_field": "left as issued; corpus-wide house provenance",
    "momentum_decisive_work_underway": "already \"Mechanistic only\"; no change needed."
  }
}